MedPath

Redpharm Drug

🇺🇸United States
Ownership
Subsidiary
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

55

FDA:55

Drug Approvals

Hydrocodone Bitartrate and Acetaminophen

Approval Date
Apr 3, 2024
FDA

Buprenorphine and Naloxone

Approval Date
Feb 15, 2024
FDA

Phenazopyridine Hydrochloride

Approval Date
Feb 14, 2024
FDA

Dicyclomine Hydrochloride

Approval Date
Feb 14, 2024
FDA

Sulfamethoxazole and Trimethoprim

Approval Date
Feb 14, 2024
FDA

Amoxicillin

Approval Date
Nov 28, 2023
FDA

HYDROCODONE BITARTRATE AND ACETAMINOPHEN

Approval Date
Nov 28, 2023
FDA

tramadol hydrochloride

Approval Date
Nov 28, 2023
FDA

Fluoxetine

Approval Date
Nov 28, 2023
FDA

Naproxen

Approval Date
Nov 27, 2023
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.